Avastin

Known as: Avastin® 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
PURPOSE To determine the serum concentrations of bevacizumab and vascular endothelial growth factor (VEGF) in infants with… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
PURPOSE To describe the pharmacokinetics of 1.25 mg of intravitreal bevacizumab (Avastin). DESIGN Experimental animal study… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Vascular endothelial growth factor (VEGF) plays an important role in many diseases of the posterior pole that are characterized… (More)
  • table 2
  • table 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2007
Highly Cited
2007
AIM To evaluate the effect of topically administered bevacizumab (Avastin) on experimental corneal neovascularisation in rats… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
PURPOSE To determine changes and need to monitor intraocular pressure (IOP) following intravitreal injection of bevacizumab… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
PURPOSE To evaluate the safety, visual acuity changes, and morphologic effects associated with intravitreal bevacizumab… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
PURPOSE Intravitreal bevacizumab (Avastin; Genentech Inc., San Francisco, CA) is a new treatment for age-related macular… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 4
  • figure 3
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Neovascular glaucoma is a secondary glaucoma with grave prognosis which follows ischemic retinal disorders in the majority of… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
To determine whether intravitreal bevacizumab could improve optical coherence tomography and visual acuity outcomes in a patient… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
To determine whether bevacizumab could improve visual acuity and optical coherence tomography outcomes in a patient with macular… (More)
Is this relevant?